A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Clinical trial NCT02965053 · COMPLETED
Trial details
- NCT number
- NCT02965053
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2018-08-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.